LAMC1 and endometrioid adenocarcinoma: Similarly, higher expression of LAMC1 is associated with a shorter tumor recurrence time and decreased patient survival in meningiomas [53], cancer cell migration, invasion in human prostate cancer cells [54], and tumor progression of the endometrioid carcinoma [55].